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ABSTRACT
DNA damage, such as abasic sites and DNA strand
breaks with 30-phosphate and 30-phosphoglycolate
termini present cytotoxic and mutagenic threats to
the cell. Class II AP endonucleases play a major role
in the repair of abasic sites as well as of 30-modified
termini. Human cells contain two class II AP endo-
nucleases, the Ape1 and Ape2 proteins. Ape1 pos-
sesses a strong AP-endonuclease activity and weak
30-phosphodiesterase and 30–50 exonuclease activit-
ies, and it is considered to be the major AP endo-
nuclease in human cells. Much less is known about
Ape2, but its importance is emphasized by the
growth retardation and dyshematopoiesis accom-
panied by G2/M arrest phenotype of the APE2-null
mice. Here, we describe the biochemical char-
acteristics of human Ape2. We find that Ape2
exhibits strong 30–50 exonuclease and 30-phosphodi-
esterase activities and has only a very weak
AP-endonuclease activity. Mutation of the active-site
residue Asp 277 to Ala in Ape2 inactivates all these
activities. We also demonstrate that Ape2 preferen-
tially acts at mismatched deoxyribonucleotides
at the recessed 30-termini of a partial DNA duplex.
Based on these results we suggest a novel role for
human Ape2 as a 30–50 exonuclease.
INTRODUCTION
Cellular DNA is subject to attack by a variety of agents of
exogenous and endogenous origins. Oxidative attack on DNA
by free radical species happens continuously during normal
cellular metabolism, generating abasic sites and DNA strand
breaks with modiﬁed 30-termini, such as 30-phosphate or
30-phosphoglycolate (30-PG) (1,2). Abasic (AP) site, which
is one of the most common lesions that arise in cellular
DNA, can also be formed due to the action of DNA glyc-
osylases on modiﬁed bases or by spontaneous base hydrolysis
(3). It has been estimated that as many as 10 000 bases are lost
spontaneously in a mammalian cell per day (4). DNA strand
breaks with blocking 30-termini can also arise due to the
b-lyase activity of some DNA glycosylases (5). The non-
coding AP-sites as well as modiﬁed 30-DNA ends are inhib-
itory to synthesis by DNA polymerases (Pols), or if bypassed,
are highly mutagenic; consequently, their repair is essential
for retaining the stability of the genome (1,2).
AP sites and single strand DNA breaks with 30 modiﬁed
termini are repaired mainly by the base excision repair (BER)
system (6,7). In BER, class II AP endonucleases play a central
role by incising the DNA 50 to AP sites to generate accessible
30-OH termini prior to repair synthesis. In addition, several
class II AP endonucleases are able to function in the removal
of 30-blocking termini thereby generating accessible 30 DNA
ends for repair synthesis by DNA polymerases (8).
Class II AP endonucleases have been classiﬁed into two
families, the exonuclease III (ExoIII) and endonuclease IV
(EndoIV) families, based on their homology to the two
Escherichia coli enzymes. In E.coli the main AP endonuclease
is ExoIII representing 90% of the cellular AP-endonuclease
activity, while Endo IV accounts for 10% of the total activity
(5). In Saccharomyces cerevisiae, the Apn1 and Apn2 proteins
represent the EndoIV and the ExoIII family, respectively
(9,10). Apn1 exhibits a strong AP-endonuclease activity
and accounts for >90% of the total AP-endonuclease activity
in yeast cells (5,11). In contrast, the Apn2 protein has
only a weak AP-endonuclease activity but exhibits a strong
30-exonuclease-phosphodiesterase activities (10,12,13). The
functional consequences of the enzymatic activities of Apn1
and Apn2 is indicated by that the apn1D strain displays a
much higher level of sensitivity to the alkylating agent
methyl-methanesulfonate (MMS) than the apn2D strain; in
contrast, neither of the single mutant strains, only the
apn1Dapn2D double mutant showed sensitivity to the oxidat-
ive agent H2O2 (12). These observations indicate that in
S.cerevisiae Apn1 has a more prominent role in the repair
of AP sites than the Apn2, whereas for the processing of
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ute equally. Contrary to these ﬁndings, in Schizosaccharomy-
ces pombe, which is generally believed to be phylogenetically
closer to mammalian cells than S.cerevisiae, Apn2 provides
the major AP-endonuclease activity while the Apn1 serves
only as a back-up activity (14).
In humans, EndoIV homologs are not known, but two
ExoIII family proteins, Ape1 and Ape2, have been identi-
ﬁed. Ape1 exhibits robust AP-endonuclease activity, which
accounts for >95% of the total cellular activity, and Ape1 is
considered to be the major AP endonuclease in human cells.
It also possesses 30-phosphodiesterase and 30 exonuclease
activities that are about two orders of magnitude less efﬁcient
than its AP-endonuclease activity (8,15).
The role and the biochemical properties of Ape2 have not
been ascertained yet. This is largely due to the difﬁculty in
the puriﬁcation of human Ape2 as its overexpression causes
extreme cytotoxicity in E.coli (16). A partially puriﬁed
sample of human Ape2 has been shown to exhibit a weak
AP-endonuclease activity (16). Its limited AP-endonuclease
activity taken together with the fact that in human cells Ape1
accounts for >95% of the total AP-endonuclease activity
indicates that human Ape2, similarly to its S.cerevisiae homo-
log may play only a limited role as an AP endonuclease. Also,
a novel role of Ape2 is suggested by recent studies that
showed that APE2-null mice have a growth retardation
phenotype which is accompanied by a G2/M arrest of prolif-
erating lymphocyes, indicating that Ape2 is required for
proper cell cycle progression (17,18). In addition, Ape2 has
been shown to localize not only to the nucleus but also to
some extent to the mitochondria, in which it may help to
maintain the function and integrity of mitochondrial DNA,
even if threatened by the attack of reactive oxygen species
produced during oxidative phosphorylation (19). These obser-
vations strongly suggest that the function of Ape1 and Ape2
proteins differs considerably in human cells.
To shed more light on the role of human Ape2, we have
puriﬁed recombinant Ape2 from yeast, and characterized it
biochemically. Here, we report novel enzymatic activities
for human Ape2. We ﬁnd that recombinant Ape2 exhibits
only a weak AP-endonuclease activity; however, it shows
strong 30–50 exonuclease and 30-phosphodiesterase activities.
Also, we show that human Ape2 is able to remove preferen-
tially mismatched 30-nucleotides from DNA. Based on these
ﬁndings, we discuss a possible role for Ape2 in processing
30-damaged termini or 30-mismatched nucleotides.
MATERIALS AND METHODS
Cloning,expressionandpurificationofthewildtypeand
mutant Ape 2 proteins
Human Ape2 cDNA was ampliﬁed by PCR from a human
cDNA library. The full-length, sequence veriﬁed PCR product
was cloned into a Gateway entry vector, pENTR3C (Invitro-
gen Corporation, Carlsbad, CA, USA) resulting in pIL1045
plasmid.ThepointmutationD277Ainthewild-typeApe2was
generated by the QuickChange site-directed mutagenesis kit
(Stratagene Corporation, La Jolla, CA, USA) and the oligo-
nucleotides O1026 (50-CTC CCG GCT TGC CTA TGT GCT
GGG-30) and O1027 (50-CCC AGC ACA TAG GCA AGC
CGG GAG-30). For expressing Ape2 proteins we cloned the
wild type and mutant Ape2 cDNA-s in fusion with glutathione
S-transferase (GST) under the control of the S.cerevisiae
galactose-inducible phosphoglycerate promoter using the
plasmid pBJ842 (20), which resulted in plasmids pIL1047
and pIL1247, respectively.
The wild type and mutant GST-Ape2 proteins were over-
expressed in parallel in the protease-deﬁcient BJ5464 yeast
strain. Cells were grown to stationer phase in synthetic
medium lacking leucine to select for the plasmids. The cul-
tures were diluted 10-fold in fresh medium lacking dextrose
but containing 2% lactic-acid and 3% glycerol followed by
incubation overnight before galactose was added to 0.2%
ﬁnal concentration. Four hours after induction cells were har-
vested and disrupted by bead beater in buffer A (20 mM
Tris–HCl, pH 7.5, 1 mM DTT, 0.01% Nonidet P-40 and
10% glycerol) supplemented with 1000 mM NaCl, 5 mM
EDTA and protease inhibitor mixture (Mini-Complete;
Roche, Indianapolis, IN). After clariﬁcation of the crude
extract by centrifugation it was loaded onto a glutathione–
Sepharose column (Amersham Pharmacia Biotech, USA).
First, the column was washed with buffer A+1000 mM
NaCl followed by washing with buffer A+100 mM NaCl.
The GST-hApe2 proteins were eluted with 20 mM reduced
glutathione in buffer A+100 mM NaCl. The Ape2-containing
fractions were collected, frozen in aliquots under liquid nitro-
gen, and stored at  80 C.
DNA substrates
DNA substrate (S1) used for the AP-endonuclease assay was
generated by annealing a 75 nt template O82 (50-TCG ATG
GTA CGG ACG GAG TTC TTA AGC ATT ATA CGG ATG
TGA CCT CAT GGC CTC GTA GCA GCA CTG ACC CTT
TTG-30) to the 75 nt 50-
32P-labeled oligomer O14 (50-CAA
AAG GGT CAG TGC TGC TAC GAG GCC ATG AGG TCA
CAT CCG TAX AAT GCT TAA GAA CTC CGT CCG TAC
CAT CGA-30). In this oligomer the X represents the place of a
single tetrahydrofuran, an abasic site analog. DNA substrate
(S2) used for the 30-phosphodiesterase assay were generated
by annealing a 70 nt template O105 (50-AGC TGG ATT CGT
GTC AGC CGC TAG CCA TTA GCT GGC GCA TTC CTC
GAG AGA GTC CCG AGC ATC GTG ACT G-30) to the 35 nt
50-
32P-labeled primer O102 (50-CAG TCA CGA TGC TCG
GGA CTC TCT CGA GGA ATG CG-PG-30) containing a
30 PG terminus. DNA substrate (S3) used for the 30–50 exo-
nuclease assay was generated by annealing a 52 nt oligomer
template O56 (50-TTC GTA TTA TGC CTA CAC TTG AGT
ACCGGAGCATCGTCGTGACTGGGAAAAC-30)tothe
33 nt 50-
32P-labeled primer, O67 (50-GTT TTC CCA GTC
ACG ACG ATG CTC CGG TAC TCA-30). DNA substrates
containing all the possible 16 bp at the primer–template
junction used for the proofreading assay in Figure 6 were
generated by annealing the 52 nt oligomer template, O56,
containing a G, A, T or C nucleotides at position 33 counting
from the 30 end to the 50-
32P-labeled primer, O67, containing
aG ,A ,To rCa t3 0 end. For generating a nick, 1, 2, 3 and 4 nt
long gap containing double-stranded DNA substrates, we
annealed three oligonucleotides, a 66 nt template oligomer
O1049 (50-AGC AAG TCA CCA ATG TCT AAG AGT
TCG TAT TAT GCC TAC ACT GGA GTA CCG GAG
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32P-labeled primer O76
(50-CGA CGA TGC TCC GGT ACT CCA GTG TAG GCA
TA-30), and a complementary 30, 29, 28, 27 or a 26 nt oligo-
mer, respectively.
30-phosphodiesterase, 30–50 exonuclease and
AP-endonuclease assays
A standard reaction mixture (10 ml) contained 40 mM
Tris–HCl (pH 7.5), 0.5 mM MnCl2, 1 mM DTT, 100 mg/ml
BSA, 10 nM DNA substrate and 5 nM Ape 2 protein. In
Figure 2B, 1 U Ape1 (Trevigene, Gaithersburg, MD) was
used. Where indicated the above buffer was supplemented
with 150 mM NaCl (Figure 2A), MnCl2 was substituted
with 8 mM MgCl2 (Figure 4A), and for experiments shown
in Figure 4E HEPES was used for pH 5.0, 5.5 and 6.0, and
Tris–HCl wasusedforpH7.0,7.5, 8.0,8.8 and10.0.Reactions
were assembled on ice, incubated at 37 C for 5 min, and
stopped by the addition of loading buffer (20 ml) containing
20 mM EDTA, 95% formamide, 0.25% xylene cyanol and
0.25% bromophenol blue. The reaction products were resol-
ved on 10% polyacrylamide gel containing 8 M urea. Quan-
tiﬁcation of the results was done using Molecular Dynamics
STORM phosphorimager and ImageQuant 5.0 software. To
eliminate error derived from unequal loading, the concentra-
tion of the reaction products were calculated from the ratio
of the intensity of bands of products to the intensity of the
total radioactivity in each lane.
RESULTS
Purification of wild type and active site mutant
Ape2 proteins
The family of ExoIII-type endonucleases contains two mem-
bers in humans, the Ape1 and Ape2 proteins. The conserved
domains involved in catalytic activity are located at the
N-terminal part of both proteins. In addition, the Ape2 protein
has a C-terminal extension, which is not present in Ape1, but
can also be found in homologs of human Ape2 such as Apn2
proteins of S.cerevisiae and S.pombe (Figure 1A) (9,10).
While Ape1 has been characterized extensively, very little
is known about the function of Ape2. Here, our goal was to
characterize the enzymatic properties of puriﬁed human Ape2
protein.
To facilitate the puriﬁcation of the Ape2 protein, the Ape2
cDNA was PCR ampliﬁed from a human cDNA library fol-
lowed by cloning it in frame downstream of the GST gene in a
yeast overexpression vector. We also made a similar construct
expressing the Ape2D277A protein containing a point muta-
tion at the D277 residue, which corresponds to a conserved
metal-binding site in the active center of class II AP endonuc-
leases (21) (Figure 1A). We expected this mutation to render
Ape2 catalytically inactive. The resulting GST–Ape2 fusion
proteins were puriﬁed from a protease-deﬁcient S.cerevisiae
strain on Glutathione–Sepharose beads. During puriﬁcation
the wild type and mutant proteins behaved similarly and
displayed identical electrophoretic mobility on a SDS–
polyacrylamide gel (Figure 1B). Western blot analysis by
anti-GST antibody conﬁrmed the dominant protein band as
GST–Ape2 and also revealed the presence of a  68 kDa
proteolytic product of Ape2 protein (data not shown).
Ape2 exhibits very weak AP-endonuclease activity
The presence of the ExoIII domain in Ape2 as well as its high
degree of homology to Ape1 had suggested that Ape2 is an
AP-endonuclease. Supporting this, a partially puriﬁed Ape2
that was expressed in E.coli has been reported to show a weak
AP-endonuclease activity (16). To examine whether the puri-
ﬁed recombinant Ape2 has an intrinsic AP-endonuclease
activity, we assayed Ape2 using a 75nt duplex DNA substrate,
in which the 50-
32P end-labeled strand contained a single
abasic site at position 31 from the 50 end. Incubation of
Ape2 with the 75 nt DNA substrate generated a 30 nt labe-
led oligomer indicating that Ape2 like other class II
AP-endonucleases incised the DNA 50 to the AP site
(Figure 2A, lanes 2 and 3). Using the Ape2 D277A mutant
protein in the same assay we could not detect any incision
of the DNA substrate conﬁrming that the D277A mutation
indeed rendered Ape2 catalytically inactive and, that the
observed AP-endonuclease activity is intrinsic to Ape2
(Figure 2A, lanes 4 and 5). AP-endonuclease reaction with
Ape1 was carried out as control for determing the incision
speciﬁcity of Ape2. Incision by Ape1 resulted in the same
30 nt reaction product generated by Ape2 (Figure 2B),
which further conﬁrms that Ape2, similarly to Ape1, incised
the DNA 50 to the AP-site. Interestingly, however, the endo-
nuclease activity of Ape1 and Ape2 showed different salt
sensitivity; the activity of Ape1 was reduced at 150 mM
A
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Figure 1. PurificationofthewildtypeandmutanthumanApe2.(A)Schematic
representationofhumanApe2.TheN-terminusofApe2containstheconserved
ExoIII domain characteristic of class II AP endonucleases, while the
C-terminus is unique to Ape2-subfamily. The arrow indicates the amino acid
D227residuethatwaschangedtoalanineintheactivesiteofApe2.(B)Purityof
wild type and mutant Ape2 proteins. Purified wild-type GST–Ape2 and
GST–Ape2D277A fusion proteins were analyzed on a 10% denaturating poly-
acrylamide gel and stained with Coomassie blue. Lane 1, molecular weight
standard; lane 2, 0.5 mg of purified GST–Ape2; lane 3, 0.5 mg of purified
GST–Ape2D277A. The arrow identifies full-length GST–Ape2, while
asterisk indicate the co-purifying proteolytic product of Ape2.
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at 0 mM NaCl concentration (Figure 2B). Measuring the salt
dependence between 0 and 300 mM NaCl concentration we
found that 150 mM NaCl concentration is optimal for the
AP-endonuclease activity of Ape2 (Figure 2C). However,
Ape2 is a weak AP-endonuclease indicated by that even at
optimal NaCl concentration Ape2 incised only 7% of the DNA
substrate despite its two and half molar excess over DNA
substrate.
Ape2 has a robust 30–50 exonuclease activity
When we examined the AP-endonuclease activity of Ape2 in a
buffer containing no NaCl, we noticed the gradual shortening
of the 75mer template that indicated an exonucleolytic diges-
tion of the DNA from the 30 end. To determine whether the
observed 30–50 exonuclease activity was intrinsic to Ape2, or
due to an exonuclease contamination of our protein sample,
we assayed the wild type and active center mutant Ape2
D277A proteins on a double-stranded DNA substrate contain-
ing a 50-
32P-labeled strand with recessed 30 terminus. Incuba-
tion of increasing amount of Ape2 with this DNA substrate
generated a series of smaller products, indicating that Ape2
exonucleotically digested the DNA from the 30 terminus
(Figure 3A, lanes 2 and 3). In contrast, the D277A active
center mutant Ape2 did not show any exonuclease activity
demonstrating that the observed robust 30–50 exonuclease
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Figure 2. AP-endonucleaseactivityofApe2.(A)TheAP-endonucleaseactivityofApe2wasassayedusinga75ntdouble-strandedDNAsubstrate(S1)containinga
single AP-site at position 31 on the 50-labeled strand. The DNA substrate (10 nM) was incubated without (lane 1) or with wild type (lanes 2–3) or D277A mutant
Ape2 (lanes 4–5) in standard reaction buffer but containing 150 mM NaCl for 5 min at 37 C. The reaction products were analyzed on 10% polyacrylamide gels
containing 8 M urea, and the DNA bands were visualized by autoradiography. The position of the incision product at 30 nt is indicated. (B) Comparison the
specificity of Ape2 and Ape1 endonuclease activities. The DNA substrate (S1) was incubated without (lane 1) or with Ape1 (lanes 2 and 4) or Ape2 (lanes 3 and 5)
in the presence or absence of 150 mM NaCl in standard reaction buffer for 5 min at 37 C. (C) The NaCl concentration dependence of the endonuclease activity of
Ape2. S1 DNA substrate (10 nM) was incubated with Ape2 (25 nM) in standard reaction buffer supplemented with 0–300 mM NaCl as indicated.
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and 5). Importantly, when the DNA substrate was in 2-fold
molar excess over Ape2, under optimal reaction conditions
Ape2 hydrolyzed nearly 100% of the exonuclease substrate
and only 7% of the AP-endonuclease substrate. Therefore
Ape2 is dominantly a 30–50 exonuclease.
30-Phosphodiesterase activity of Ape2
Next we tested whether Ape2 is also able to remove 30-block-
ing termini. For this we constructed a DNA substrate by
annealing a 70 nt long oligonucleotide to a 35 nt oligomer
containing a 30-PG terminus. Enzymatic removal of the 30-PG
results in a 30-hydroxyl terminus (30-OH), and 30-PG is
released in the form of phosphoglycolic acid. The 30-OH
group confers lower electrophoretic mobility to the 35 nt oli-
gomer on a denaturing polyacrylamide gel. Incubation of
Ape2 with the PG-containing DNA substrate resulted in the
appearance of a lower mobility band on the gel, which indic-
ated that Ape2 had a 30-phosphodiesterase activity (Figure 3B,
lanes 2 and 3). Unlike the wild-type protein, the Ape2 D277A
mutant did not exhibit such an activity (Figure 3B, lanes 4
and 5). These results indicate that the Ape2 protein has a
30-phosphodiesterase activity.
DNA substrate specificity and enzymatic characteristics
of Ape2 exonuclease
To characterize further Ape2 exonuclease, ﬁrst we examined
for its optimal reaction conditions. The exonuclease activity
of Ape2 was strongly dependent upon metal ion. Ape2 was
 5-fold more active in the presence of manganese than of
magnesium ion (Figure 4A and B). Addition of salt inhibited
the exonuclease activity, and at 100 mM NaCl concentration
Ape2 exhibited only 20% of its exonuclease activity meas-
ured in buffer containing no salt (Figure 4C and D), and in
the presence of 200 mM salt almost no exonuclease activity
could be detected. The Ape2 showed optimal activity in the
pH range of 6.0–8.0 (Figure 4E and F).
To determine the DNA substrate requirement for the exo-
nuclease activity, we compared the exonuclease activity of
Ape2 for its ability to hydrolyze single-stranded DNA,
blunt-ended duplex DNA, partial DNA duplexes with either
a protruding or a recessed 30-terminus or a single nucleotide
gap containing heteroduplex DNA. As shown on Figure 5A,
Ape2 exhibited the strongest exonuclease activity on a
recessed 30 end containing partial DNA duplex (Figure 5A,
lane 8) and fairly strong activity on a single nucleotide gap
containingheteroduplexDNA(Figure5A,lane10).Inaddition,
Ape2 also exhibited exonuclease activity on blunt-ended
substrate (Figure 5A, lane 6). However, Ape2 showed only
residual activity on single-stranded DNA and protruding
30-terminus.
Short-patch BER proceeds via a nick and asinglenucleotide
gap containing heteoduplex DNA. To examine whether Ape2
has any preferences for these DNA substrates, we compared
the exonuclease activity of Ape2 on a nick and 1, 2, 3 or 4 nt
long gap containing DNA duplexes. Our results revealed that
Ape2 exonuclease had 2-fold stronger activity on a single
nucleotide gap containing substrate than on a nicked DNA,
and increasing the gap size from 1 to 4 nt did not make sig-
niﬁcant difference (Figure 5B and C).
30-Mispair specific exonuclease activity of Ape2
To examine the effect of base–base hydrogen bounding at the
primer–template junction on the exonuclease activity of Ape2,
we assayed Ape2 on various combinations of recessed DNA
with 30-mispairs as substrates. Figure 6 shows the exonuclease
activity of Ape2 on DNA substrates containing all the 16 pos-
sible base pairing at the 30 end. Quantiﬁcation revealed that
Ape2 removed 30 mismatched nucleotides 2- to 40-fold more
efﬁciently than those matched correctly (Figure 6). For
example, Ape2 had a very limited activity on a 30 recessed
DNA duplex containing a matched 30A opposite from a tem-
plate T (Figure 6, lane 3); however, it exhibited a strong
nuclease activity on a DNA containing unmatched 30 A oppo-
site from G, A or C (Figure 6, lanes 2, 4 and 5). From these
experiments we conclude that Ape2 exonuclease has a signi-
ﬁcant preference for mispaired nucleotides at the recessed
30 end of DNA.
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Figure 3. 30-Exonuclease and 30-phosphodiesterase activities of Ape2. (A) The 30–50 exonuclease activity of wild-type (lanes 2 and 3) and mutant (lanes 4 and 5)
Ape2 was assayed on partial DNA duplex (S3) (10 nM) in standard reaction buffer for 5 min at 37 C. (B) The phosphodiesterase activity of Ape2 was tested on a
DNA substrate (S2) containing a 50-labeled 35 nt oligomer with a 30-PG terminus annealed to a 70 nt oligomer. Wild type (lanes 2 and 3) and mutant (lanes 4 and 5)
Ape2 proteins were incubated with 10 nM DNA substrates in standard reaction buffer for 5 min at 37 C. The positions of the reaction product and the substrate
are indicated by 30-OH and 30-PG, respectively.
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In this study, we have clariﬁed the enzymatic activities of
human Ape2 and show that it is a multifunctional enzyme.
Ape2 has only a weak AP endonuclease, a fairly strong
30-phosphodiesterase, but a robust 30–50exonuclease activity.
Importantly, we reveal that the Ape2 exonuclease is most
active on 30-recessed heteroduplex DNA and is able to remove
mismatched nucleotides preferentially.
All the proteins of the ExoIII family share the highly con-
served ExoIII-domain in the N-terminus but proteins in the
new Apn2 subfamily within the ExoIII family contain an addi-
tional C-terminal extension. While the classical ExoIII-type
AP-endonucleases have been studied extensively, very little
is known about the proteins of the Apn2 subfamily. Previ-
ously, we have studied the Apn2 protein of S.cerevisiae and
shown that it provides only a back-up AP-endonuclease activ-
ity but plays an important role in the repair of DNA strand
breaks arising from the reaction of DNA with reactive oxygen
species (10,12,13). In contrast, in S.pombe cells Apn2 appears
to be the major AP endonuclease (14). Our current study
indicates that the enzymatic properties of Ape2 are more
similar to those of Apn2 of S.cerevisiae than to those of
Apn2 of S.pombe.
Previously, Ape2 has been puriﬁed only partially due to its
insolubility and its cytotoxicity on the E.coli and it has been
shown to possess a very weak AP-endonuclease activity (16).
In agreement with that study, our attempt to purify active
recombinant Ape2 from E.coli was not successful. However,
wemanaged toovercometheproblembyoverexpressingApe2
in fusion with GST in the yeast S.cerevisiae. To conﬁrm
that the observed 30-exonuclease, 30-phosphodiesterase and
the extremely weak AP-endonuclease activities are intrinsic
to Ape2, we also puriﬁed a mutant Ape2 protein, in which we
altered the conserved Asp277 residue to Ala. This amino acid
in Ape2 is equivalent to residues Asp328 in S.cerevisiae
Apn2, and Asp283 in human Ape1, which have been shown
to be involved in metal binding (21). As expected, the Ape2
D277A protein did not show activity in any of the enzymatic
assays thereby conﬁrming that the detected AP-endonuclease,
30-phosphodiesterase and 30-exonuclease activities are intri-
nsic to Ape2.
It has been published recently that APE2-null mice show
abnormalities in proliferating haemopoietic organs, such as
dyshaematopoiesis, defect in lymphopoiesis, and delayed
S-phase and G2/M-phase arrest. It has been suggested that
the increased accumulation of AP sites in the absence of
the AP-endonuclease activity of Ape2 is the underlying
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Nucleic Acids Research, 2006, Vol. 34, No. 9 2513cause of these phenotypes (17,18). However, our biochemical
data show a very inefﬁcient AP-endonuclease activity of Ape2
arguing that this activity cannot play a major role in vivo.I n
contrast, owing to its signiﬁcant 30-phosphodiesterase activity,
Ape2 might have a major function in the removal of 30-PG
terminiformed inDNA byoxidative agents.Thistheoryisalso
supported by our previous study, in which we provided genetic
evidence for the involvement of S.cerevisiae Apn2 in the
repair of 30-PG residues (12).
Another clue for the main function of Ape2 can be found in
its strong 30–50 exonuclease activity and in its preference for
removing mismatched nucleotides from the 30 primer end.
Ape2 might have a role as a proofreader in processes where
new DNA synthesis occurs such as DNA repair synthesis.
During short patch BER, Polb carries out the DNA synthetic
step. However, Polb lacks proofreading exonuclease activity,
and it is quite error prone making an average one mistake per
4000 base insertions. Without any proofreading mechanism,
Polb would introduce several mutations into the genome of
each cell per day. Human Ape1 protein has been shown
already to be able to proofread the errors of Polb (22). It is
possible that Ape2 could also function as an alternative proof-
reader for Polb and thereby improve the ﬁdelity of BER.
Recently, several class II AP endonucleases such as yeast
Apn1 and human Ape1 have been demonstrated to be able to
remove 30 incorporated 8-oxodG damaged nucleotide (23,24).
Further studies should determine, whether Ape2 can also func-
tion in the cleansing of 30 end of newly synthesized DNA
from 8-oxodG, or other damaged nucleotides.
One might question the need for an exonuclease for the
removal of mismatches or 8-oxodG from the 30-termini of
newly synthesized DNA when cells contain MSH2 complexes
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2514 Nucleic Acids Research, 2006, Vol. 34, No. 9to recognize these errors and to eliminate them by mismatch
repair mechanisms. However, class II AP exonucleases can
provide a backup mechanism to the mismatch repair system.
Yeast genetic experiments have already indicated that beside
mismatch repair system, the 30 exonuclease activity of Apn1
functions in an alternative way for prevention the mutagenic
threat of 8-oxodG (23).
In summary, our biochemical characterization of Ape2 sup-
port a main function for Ape2 as a 30-exonuclease and predicts
its involvement in the processing of 30-blocking termini or
30 mismatched nucleotides of newly synthesized DNA.
ACKNOWLEDGEMENTS
We thank Katalin Illesne Kovacs for technical assistance. This
work was supported by The Wellcome Trust International
Senior Research Fellowship, the Hungarian Science
Foundation Grant (OTKA T043354 nad NF61921), the Marie
Curie International Reintegration Grant (grant 022 345), the
Howard Hughes Medical Institutes (grant 55 005 612) and
the EMBO restart fellowship. Funding to pay the Open
Access publication charges for this article was provided by
Marie Curie International Reintegration Grant 022345.
Conflict of interest statement. None declared.
REFERENCES
1. Demple,B. and Harrison,L. (1994) Repair of oxidative damage to
DNA—enzymology and biology. Ann. Rev. Biochem., 63, 915–948.
2. Henle,E.S. and Linn,S. (1997) Formation, prevention, and repair of
DNA damage by iron hydrogen peroxide. J. Biol. Chem., 272,
19095–19098.
3. Boiteux,S. and Guillet,M. (2004) Abasic sites in DNA: repair and
biological consequences in Saccharomyces cerevisiae. DNA Repair,
3, 1–12.
4. Lindahl,T. and Nyberg,B. (1972) Rate of depurination of native
deoxyribonucleic acid. Biochemistry, 11, 3610–3617.
5. Seeberg,E., Eide,L. and Bjoras,M. (1995) The base excision-repair
pathway. Trends Biochem. Sci., 20, 391–397.
6. Mitra,S., Hazra,T.K., Roy,R., Ikeda,S., Biswas,T., Lock,J., Boldogh,I.
and Izumi,T. (1997) Complexities of DNA base excision repair in
mammalian cells. Mol. Cells, 7, 305–312.
7. Mitra,S., Boldogh,I., Izumi,T. and Hazra,T.K. (2001) Complexities of
the DNA base excision repair pathway for repair of oxidative DNA
damage. Environ. Mol. Mutagen., 38, 180–190.
8. Suh,D., Wilson,D.M. and Povirk,L.F. (1997) 30-Phosphodiesterase
activity of human apurinic/apyrimidinic endonuclease at DNA
double-strand break ends. Nucleic Acids Res., 25, 2495–2500.
9. Johnson,R.E., Torres-Ramos,C.A., Izumi,T., Mitra,S., Prakash,S. and
Prakash,L. (1998) Identification of APN2, the Saccharomyces
cerevisiae homolog of the major human AP endonuclease HAP1, and its
role in the repair of abasic sites. Genes Dev., 12, 3137–3143.
10. Unk,I., Haracska,L., Johnson,R.E., Prakash,S. and Prakash,L. (2000)
Apurinic endonuclease activity of yeast Apn2 protein. J. Biol. Chem.,
275, 22427–22434.
11. Popoff,S.C., Spira,A.I., Johnson,A.W. and Demple,B. (1990) Yeast
structural gene (Apn1) for the major apurinic endonuclease—homology
to Escherichia coli endonuclease-IV. Proc. Natl Acad. Sci. USA, 87,
4193–4197.
12. Unk,I., Haracska,L., Prakash,S. and Prakash,L. (2001) 30-
Phosphodiesterase and 30!50 exonuclease activities of yeast Apn2
protein and requirement of these activities for repair of oxidative DNA
damage. Mol. Cell. Biol., 21, 1656–1661.
13. Unk,I., Haracska,L., Gomes,X.V., Burgers,P.M.J., Prakash,L. and
Prakash,S. (2002) Stimulation of 30!50 exonuclease and
30-phosphodiesterase activities of yeast Apn2 by proliferating cell
nuclear antigen. Mol. Cell. Biol., 22, 6480–6486.
14. Ribar,B., Izumi,T. and Mitra,S. (2004) The major role of human
AP-endonuclease homolog Apn2 in repair of abasic sites in
Schizosaccharomyces pombe. Nucleic Acids Res., 32, 115–126.
15. Wilson,D.M., Takeshita,M., Grollman,A.P. and Demple,B. (1995)
Incision activity of human apurinic endonuclease (Ape) at abasic site
analogs in DNA. J. Biol. Chem., 270, 16002–16007.
16. Hadi,M.Z. and Wilson,D.M. (2000) Second human protein with
homology to the Escherichia coli abasic endonuclease exonuclease III.
Environ. Mol. Mutagen., 36, 312–324.
17. Ide,Y., Tsuchimoto,D., Tominaga,Y., Iwamoto,Y. and Nakabeppu,Y.
(2003) Characterization of the genomic structure and expression of the
mouse Apex2 gene. Genomics, 81, 47–57.
18. Ide,Y., Tsuchimoto,D., Tominaga,Y., Nakashima,M., Watanabe,T.,
Sakumi,K., Ohno,M. and Nakabeppu,Y. (2004) Growth retardation and
dyslymphopoiesis accompanied by G2/M arrest in APEX2-null mice.
Blood, 104, 4097–4103.
19. Tsuchimoto,D., Sakai,Y., Sakumi,K., Nishioka,K., Sasaki,M.,
Fujiwara,T. and Nakabeppu,Y. (2001) Human APE2 protein is mostly
localized in the nuclei and to some extent in the mitochondria, while
nuclear APE2 is partly associated with proliferating cell
nuclear antigen. Nucleic Acids Res., 29, 2349–2360.
20. Johnson,R.E., Yu,S.L., Prakash,S. and Prakash,L. (2003) Yeast DNA
polymerase zeta (zeta) is essential for error-free replication past thymine
glycol. Genes Dev., 17, 77–87.
21. Mol,C.D., Izumi,T., Mitra,S. and Tainer,J.A. (2000) DNA-bound
structures and mutants reveal abasic DNA binding by APE1 DNA repair
and coordination. Nature, 403, 451–456.
22. Chou,K.M. and Cheng,Y.C. (2002) An exonucleolytic activity of human
apurinic/apyrimidinic endonuclease on 30 mispaired DNA. Nature, 415,
655–659.
23. Ishchenko,A.A., Yang,X.M., Ramotar,D. and Saparbaev,M. (2005) The
30!50 exonuclease of Apn1 provides an alternative pathway to repair
7,8-dihydro-8-oxodeoxyguanosine in Saccharomyces cerevisiae.
Mol. Cell. Biol., 25, 6380–6390.
24. Parsons,J.L., Dianova,I.I. and Dianov,G.L. (2005) APE1-dependent
repair of DNA single-strand breaks containing 30-end 8-oxoguanine.
Nucleic Acids Res., 33, 2204–2209.
Nucleic Acids Research, 2006, Vol. 34, No. 9 2515